MAD2L1 and neoplasm: Future work is expected to show if analysis of Mad2-targeting miRNAs’ expression and/or epigenetic status of the 14q32 locus has diagnostic value in cancer subtyping or in prediction of tumor cells’ sensitivity to clinically utilized microtubule drugs.